{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T05:06:51Z","timestamp":1781327211091,"version":"3.54.1"},"reference-count":89,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T00:00:00Z","timestamp":1602115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.571166","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T08:59:46Z","timestamp":1602147586000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["Reversal of Immunity After Clearance of Chronic HCV Infection\u2014All Reset?"],"prefix":"10.3389","volume":"11","author":[{"given":"Heiner","family":"Wedemeyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanvi","family":"Khera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Strunz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas K.","family":"Bj\u00f6rkstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,10,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2015.227","article-title":"HCV in 2015: Advances in hepatitis C research and treatment","volume":"13","author":"Rehermann","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI80566","article-title":"HIV-specific CD8(+) T cells and HIV eradication","volume":"126","author":"Jones","year":"2016","journal-title":"J Clin Invest"},{"key":"B3","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1016\/j.jhep.2016.01.028","article-title":"The role of innate immunity in the immunopathology and treatment of HBV infection","volume":"64","author":"Maini","year":"2016","journal-title":"J Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02290","article-title":"NK Cells in HIV-1 Infection: From Basic Science to Vaccine Strategies","volume":"9","author":"Florez-Alvarez","year":"2018","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.06.035","article-title":"Innate and adaptive immune responses in HCV infections","volume":"61","author":"Heim","year":"2014","journal-title":"J Hepatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/imcb.12008","article-title":"MAIT cells and viruses","volume":"96","author":"Ussher","year":"2018","journal-title":"Immunol Cell Biol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1172\/JCI121960","article-title":"Circulating and intrahepatic antiviral B cells are defective in hepatitis B","volume":"128","author":"Burton","year":"2018","journal-title":"J Clin Invest"},{"key":"B8","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jhep.2016.08.009","article-title":"The role of quantitative hepatitis B surface antigen revisited","volume":"66","author":"Cornberg","year":"2017","journal-title":"J Hepatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-017-0641-1","article-title":"Tolerance and immunity to pathogens in early life: insights from HBV infection","volume":"39","author":"Hong","year":"2017","journal-title":"Semin Immunopathol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.10.002","article-title":"T cell regulation in HBV-related chronic liver disease","volume":"66","author":"Ferrari","year":"2017","journal-title":"J Hepatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI3731","article-title":"Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B","volume":"102","author":"Boni","year":"1998","journal-title":"J Clin Invest"},{"key":"B12","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1053\/j.gastro.2012.07.014","article-title":"Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues","volume":"143","author":"Boni","year":"2012","journal-title":"Gastroenterology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.09.003","article-title":"CD8(+) T Cells and cART: A Dynamic Duo","volume":"45","author":"Gaiha","year":"2016","journal-title":"Immunity"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-306767","article-title":"Effects of HDV infection and pegylated interferon alpha treatment on the natural killer cell compartment in chronically infected individuals","volume":"64","author":"Lunemann","year":"2015","journal-title":"Gut"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit561","article-title":"Compromised function of natural killer cells in acute and chronic viral hepatitis","volume":"209","author":"Lunemann","year":"2014","journal-title":"J Infect Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28155","article-title":"Natural killer cell phenotype modulation and natural killer\/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B","author":"Boni","year":"2015","journal-title":"Hepatol (Baltimore Md"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy097","article-title":"Increased NK Cell Function After Cessation of Long-Term Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Is Associated With Liver Damage and HBsAg Loss","volume":"217","author":"Zimmer","year":"2018","journal-title":"J Infect Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/nri1711","article-title":"NK cells in HIV infection: paradigm for protection or targets for ambush","volume":"5","author":"Fauci","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2010.08.003","article-title":"CD56 negative NK cells: origin, function, and role in chronic viral disease","volume":"31","author":"Bjorkstrom","year":"2010","journal-title":"Trends Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-06-226332","article-title":"The decreased expression of Siglec-7 represents an early marker of dysfunctional natural killer-cell subsets associated with high levels of HIV-1 viremia","volume":"114","author":"Brunetta","year":"2009","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.04.009","article-title":"Chronic hepatitis delta virus infection leads to functional impairment and severe loss of MAIT cells","volume":"71","author":"Dias","year":"2019","journal-title":"J Hepatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-07-445429","article-title":"Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection","volume":"121","author":"Leeansyah","year":"2013","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-06-436436","article-title":"Early and nonreversible decrease of CD161++ \/MAIT cells in HIV infection","volume":"121","author":"Cosgrove","year":"2013","journal-title":"Blood"},{"key":"B24","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","article-title":"EASL Recommendations on Treatment of Hepatitis C 2018","volume":"69","author":"Guidelines","year":"2018","journal-title":"J Hepatol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.02.023","article-title":"EASL Clinical Practice Guidelines: management of hepatitis C virus infection","volume":"55","author":"Guidelines","year":"2011","journal-title":"J Hepatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.02.006","article-title":"From non-A, non-B hepatitis to hepatitis C virus cure","volume":"62","author":"Pawlotsky","year":"2015","journal-title":"J Hepatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.076646","article-title":"Treating viral hepatitis C: efficacy, side effects, and complications","volume":"55","author":"Manns","year":"2006","journal-title":"Gut"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.07.025","article-title":"Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression","volume":"67","author":"Waziry","year":"2017","journal-title":"J Hepatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.07.001","article-title":"Impact of direct-acting antiviral therapy on the need for liver transplantation related to hepatitis C in Germany","volume":"69","author":"Herzer","year":"2018","journal-title":"J Hepatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14427","article-title":"Interferon-free therapy of chronic hepatitis C with direct-acting antivirals does not change the short-term risk for de novo hepatocellular carcinoma in patients with liver cirrhosis","volume":"47","author":"Mettke","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27971","article-title":"Temporal dynamics of inflammatory cytokines\/chemokines during sofosbuvir and ribavirin therapy for genotype 2 and 3 hepatitis C infection","volume":"62","author":"Carlin","year":"2015","journal-title":"Hepatology"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw457","article-title":"Direct-Acting Antiviral-Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients With Chronic Hepatitis C","volume":"214","author":"Hengst","year":"2016","journal-title":"J Infect Dis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.10.035","article-title":"Levels of Cytokines in Serum Associate With Development of Hepatocellular Carcinoma in Patients With HCV Infection Treated With Direct-Acting Antivirals","volume":"154","author":"Debes","year":"2018","journal-title":"Gastroenterology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1038\/s41598-020-58768-z","article-title":"Plasma FABP4 is associated with liver disease recovery during treatment-induced clearance of chronic HCV infection","volume":"10","author":"Gorin","year":"2020","journal-title":"Sci Rep"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.05.043","article-title":"Restoration of HCV-specific CD8+ T cell function by interferon-free therapy","volume":"61","author":"Martin","year":"2014","journal-title":"J Hepatol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15050","article-title":"TCF1(+) hepatitis C virus-specific CD8(+) T cells are maintained after cessation of chronic antigen stimulation","volume":"8","author":"Wieland","year":"2017","journal-title":"Nat Commun"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.06.025","article-title":"Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses","volume":"71","author":"Aregay","year":"2019","journal-title":"J Hepatol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1172\/JCI129642","article-title":"Follicular T helper cells shape the HCV-specific CD4 T cell repertoire after viral elimination","volume":"130","author":"Smits","year":"2019","journal-title":"J Clin Invest"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.12.019","article-title":"Increased peripheral CD4(+) regulatory T cells persist after successful direct-acting antiviral treatment of chronic hepatitis C","volume":"66","author":"Langhans","year":"2017","journal-title":"J Hepatol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00510","article-title":"Human gammadelta T Cell Receptor Repertoires in Peripheral Blood Remain Stable Despite Clearance of Persistent Hepatitis C Virus Infection by Direct-Acting Antiviral Drug Therapy","volume":"9","author":"Ravens","year":"2018","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13121","article-title":"Persistent gamma delta T-cell dysfunction in chronic HCV infection despite direct-acting antiviral therapy induced cure","volume":"29","author":"Ghosh","year":"2019","journal-title":"J Viral Hepat"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201646447","article-title":"Nonreversible MAIT cell-dysfunction in chronic hepatitis C virus infection despite successful interferon-free therapy","volume":"46","author":"Hengst","year":"2016","journal-title":"Eur J Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159243","article-title":"Frequencies of Circulating MAIT Cells Are Diminished in Chronic HCV, HIV and HCV\/HIV Co-Infection and Do Not Recover during Therapy","volume":"11","author":"Spaan","year":"2016","journal-title":"PloS One"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1053\/j.gastro.2017.07.043","article-title":"Intra-Hepatic Depletion of Mucosal-Associated Invariant T Cells in Hepatitis C Virus-Induced Liver Inflammation","volume":"153","author":"Bolte","year":"2017","journal-title":"Gastroenterology"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201948152","article-title":"Successful direct-acting antiviral therapy in HIV\/HCV co-infected patients fails to restore circulating mucosal-associated invariant T cells","volume":"49","author":"Cannizzo","year":"2019","journal-title":"Eur J Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1053\/j.gastro.2015.03.004","article-title":"Successful Interferon-Free Therapy of Chronic Hepatitis C Virus Infection Normalizes Natural Killer Cell Function","volume":"149","author":"Serti","year":"2015","journal-title":"Gastroenterology"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv391","article-title":"Immunological Analysis During Interferon-Free Therapy for Chronic Hepatitis C Virus Infection Reveals Modulation of the Natural Killer Cell Compartment","volume":"213","author":"Spaan","year":"2016","journal-title":"J Infect Dis"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1038\/s41467-018-04685-9","article-title":"Chronic hepatitis C virus infection irreversibly impacts human natural killer cell repertoire diversity","volume":"9","author":"Strunz","year":"2018","journal-title":"Nat Commun"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i40.4554","article-title":"Recovery of natural killer cells is mainly in post-treatment period in chronic hepatitis C patients treated with sofosbuvir plus ledipasvir","volume":"24","author":"Wang","year":"2018","journal-title":"World J Gastroenterol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s10238-019-00564-9","article-title":"Direct antiviral agents upregulate natural killer cell potential activity in chronic hepatitis C patients","volume":"19","author":"Jiang","year":"2019","journal-title":"Clin Exp Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1166","article-title":"Early and late changes in natural killer cells in response to ledipasvir\/sofosbuvir treatment","volume":"2","author":"Golden-Mason","year":"2018","journal-title":"Hepatol Commun"},{"key":"B52","doi-asserted-by":"crossref","DOI":"10.1002\/hep.31273","article-title":"Adaptive Natural Killer Cell Functional Recovery in Hepatitis C Virus Cured Patients","volume-title":"Hepatol (Baltimore Md)","author":"Mele","year":"2020"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1258","article-title":"Multitarget Direct-Acting Antiviral Therapy Is Associated With Superior Immunologic Recovery in Patients Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus","volume":"2","author":"Shrivastava","year":"2018","journal-title":"Hepatol Commun"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12702","article-title":"Augmentation of hepatitis C virus-specific immunity and sustained virologic response","volume":"24","author":"Shrivastava","year":"2017","journal-title":"J Viral Hepat"},{"key":"B55","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s41467-019-14137-7","article-title":"Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection","volume":"11","author":"Barili","year":"2020","journal-title":"Nat Commun"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12465","article-title":"Memory re-differentiation and reduced lymphocyte activation in chronic HCV-infected patients receiving direct-acting antivirals","volume":"22","author":"Burchill","year":"2015","journal-title":"J Viral Hepat"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1325-x","article-title":"TOX transcriptionally and epigenetically programs CD8(+) T cell exhaustion","volume":"571","author":"Khan","year":"2019","journal-title":"Nature"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1324-y","article-title":"TOX is a critical regulator of tumour-specific T cell differentiation","volume":"571","author":"Scott","year":"2019","journal-title":"Nature"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1326-9","article-title":"TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection","volume":"571","author":"Alfei","year":"2019","journal-title":"Nature"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aba7918","article-title":"TOX is expressed by exhausted and polyfunctional human effector memory CD8(+) T cells","volume":"5","author":"Sekine","year":"2020","journal-title":"Sci Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00270","article-title":"Type I Interferon Elevates Co-Regulatory Receptor Expression on CMV- and EBV-Specific CD8 T Cells in Chronic Hepatitis C","volume":"6","author":"Owusu Sekyere","year":"2015","journal-title":"Front Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000490360","article-title":"HCC Immune Surveillance and Antiviral Therapy of Hepatitis C Virus Infection","volume":"8","author":"Owusu Sekyere","year":"2019","journal-title":"Liver Cancer"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27278","article-title":"T-cell immunity and hepatitis C virus reinfection after cure of chronic hepatitis C with an interferon-free antiviral regimen in a chimpanzee","author":"Callendret","year":"2014","journal-title":"Hepatol (Baltimore Md"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3298","article-title":"The burgeoning family of unconventional T cells","volume":"16","author":"Godfrey","year":"2015","journal-title":"Nat Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032713-120216","article-title":"gammadelta T cells: first line of defense and beyond","volume":"32","author":"Chien","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/srep26296","article-title":"Functional dichotomy of Vdelta2 gammadelta T cells in chronic hepatitis C virus infections: role in cytotoxicity but not for IFN-gamma production","volume":"6","author":"Yin","year":"2016","journal-title":"Sci Rep"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3283611888","article-title":"The gammadelta T-cell receptor repertoire is reconstituted in HIV patients after prolonged antiretroviral therapy","volume":"27","author":"Chaudhry","year":"2013","journal-title":"AIDS (Lond Engl)"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-303339","article-title":"Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells","volume":"117","author":"Dusseaux","year":"2011","journal-title":"Blood"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11653","article-title":"MAIT cells are activated during human viral infections","volume":"7","author":"van Wilgenburg","year":"2016","journal-title":"Nat Commun"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-314458","article-title":"Mucosa-associated invariant T cells link intestinal immunity with antibacterial immune defects in alcoholic liver disease","volume":"67","author":"Riva","year":"2018","journal-title":"Gut"},{"key":"B71","doi-asserted-by":"crossref","DOI":"10.1002\/hep.31153","article-title":"MAIT cells are enriched and highly functional in ascites of patients with decompensated liver cirrhosis","volume-title":"Hepatol (Baltimore Md)","author":"Niehaus","year":"2020"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2011.02.031","article-title":"Immune dysfunction and infections in patients with cirrhosis","volume":"9","author":"Bonnel","year":"2011","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001760","article-title":"IL-7 treatment supports CD8+ mucosa-associated invariant T-cell restoration in HIV-1-infected patients on antiretroviral therapy","volume":"32","author":"Sortino","year":"2018","journal-title":"AIDS (Lond Engl)"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.34","article-title":"Emerging insights into natural killer cells in human peripheral tissues","volume":"16","author":"Bjorkstrom","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.immuni.2013.12.010","article-title":"Immune responses to HCV and other hepatitis viruses","volume":"40","author":"Park","year":"2014","journal-title":"Immunity"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1126\/science.1097670","article-title":"HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection","author":"Khakoo","year":"2004","journal-title":"Sci (New York NY"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.01.051","article-title":"Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection","volume":"138","author":"Stegmann","year":"2010","journal-title":"Gastroenterology"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.076463","article-title":"Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C","volume":"55","author":"Nattermann","year":"2006","journal-title":"Gut"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25723","article-title":"Impaired intrahepatic natural killer cell cytotoxic function in chronic hepatitis C virus infection","volume":"56","author":"Varchetta","year":"2012","journal-title":"Hepatol (Baltimore Md"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25302","article-title":"The effects of direct-acting antiviral agents on the frequency of myeloid-derived suppressor cells and natural killer cells in patients with chronic hepatitis C","volume":"91","author":"Li","year":"2019","journal-title":"J Med Virol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310033","article-title":"Rapid decrease in hepatitis C viremia by direct acting antivirals improves the natural killer cell response to IFNalpha","volume":"66","author":"Serti","year":"2017","journal-title":"Gut"},{"key":"B82","doi-asserted-by":"publisher","first-page":"208ra145","DOI":"10.1126\/scitranslmed.3006702","article-title":"Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry","volume":"5","author":"Horowitz","year":"2013","journal-title":"Sci Trans Med"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02692","article-title":"29-Color Flow Cytometry: Unraveling Human Liver NK Cell Repertoire Diversity","volume":"10","author":"Filipovic","year":"2019","journal-title":"Front Immunol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1084\/jem.20100762","article-title":"Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus","volume":"208","author":"Bjorkstrom","year":"2011","journal-title":"J Exp Med"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-10-459545","article-title":"NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs","volume":"121","author":"Beziat","year":"2013","journal-title":"Blood"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201445369","article-title":"High-resolution determination of human immune cell signatures from fine-needle liver aspirates","volume":"45","author":"Hengst","year":"2015","journal-title":"Eur J Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1008181","article-title":"Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals","volume":"15","author":"Perez","year":"2019","journal-title":"PloS Genet"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-311292","article-title":"Epigenetics in liver disease: from biology to therapeutics","volume":"65","author":"Hardy","year":"2016","journal-title":"Gut"},{"key":"B89","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1053\/j.gastro.2019.02.038","article-title":"HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response","volume":"156","author":"Hamdane","year":"2019","journal-title":"Gastroenterology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.571166\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T08:59:48Z","timestamp":1602147588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.571166\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,8]]},"references-count":89,"alternative-id":["10.3389\/fimmu.2020.571166"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.571166","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,8]]},"article-number":"571166"}}